000			02223nam a22003857a 4500
008			240723s20232023 xxu||||| |||| 00| 0 eng d
022			_a2000-9666
024			_ajchim-13-06-080 [pii]
024			_aPMC11000852 [pmc]
040			_aOvid MEDLINE(R)
099			_a38596551
245			_aSevere Thrombocytopenia in Infective Endocarditis.
251			_aJournal of Community Hospital Internal Medicine Perspectives. 13(6):80-82, 2023.
252			_aJ Community Hosp Intern Med Perspect. 13(6):80-82, 2023.
253			_aJournal of community hospital internal medicine perspectives
260			_c2023
260			_p2023
260			_fFY2024
265			_sepublish
265			_tPubMed-not-MEDLINE
520			_aThrombocytopenia can be seen in about 20-25% of patients with bacterial infective endocarditis (IE). Platelets have a major role in the pathogenesis of endocarditis, and they are also sensitive monitors of systemic host response to bacteremia. Thrombocytopenia on presentation of patients with IE identifies higher risk groups and carries higher mortality risk. The presence of thrombocytopenia is an independent prognosticator of poor outcomes in IE. We present a case of a 40-year-old male with the history of injection drug use who was diagnosed with IE and was found to have severe thrombocytopenia on admission was treated with intravenous antibiotics, which dramatically improved his platelet counts as well without any need for plasmapheresis or platelet transfusions. Copyright © 2023 Greater Baltimore Medical Center.
546			_aEnglish
650			_zAutomated
651			_aMedStar Franklin Square Medical Center
651			_aMedStar Union Memorial Hospital
656			_aInternal Medicine Residency
657			_aCase Reports
700			_aAdhikari, Biplov _bMUMH _cInternal Medicine Residency _dMBBS
700			_aDevkota, Amrit _bMUMH _cInternal Medicine Residency _dMBBS
700			_aMohebtash, Mahsa _bMFSMC
700			_aPatel, Mayuri _bMUMH _cInternal Medicine Residency _dMD
790			_aPatel M, Adhikari B, Devkota A, Mohebtash M
856			_uhttps://dx.doi.org/10.55729/2000-9666.1272 _zhttps://dx.doi.org/10.55729/2000-9666.1272
942			_cART _dArticle
999			_c14237 _d14237